Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-25 @ 2:50 AM
NCT ID:
NCT02267733
Eligibility Criteria:
Inclusion Criteria:
* Understand and voluntarily sign an informed consent document
* Age \>= 18 years at the time of signing the informed consent form
* Diagnosis of any monoclonal gammopathy; Monoclonal Gammopathy of Undetermined Significance (MGUS), asymptomatic/ active multiple myeloma, asymptomatic / active Waldenstrom Macroglobulinemia (WM)
Exclusion Criteria:
* An serious egg allergy or prior serious adverse reaction to an influenza vaccine
* Use of any other influenza vaccine for the 2014 to 2015 flu season
* Women who are pregnant or plan to become pregnant in the study period
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02267733
Study Brief:
Protocol Section:
NCT02267733